Network origin in Scott A. Katzmann first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.
15
| Private Company | Investment Managers | 15 |
Western Water Co.
 Western Water Co. Water UtilitiesUtilities Western Water Co. develops and sells water and water rights. The private company is based in San Diego, CA. The company was founded by Peter L. Jensen.
5
| Private Company | Water Utilities | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Scott A. Katzmann via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| EMISPHERE TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VIOQUEST PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Director/Board Member Chairman Director/Board Member | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Founder Founder | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Founder Corporate Officer/Principal Private Equity Investor | |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
Cordova Sciences, Inc.
 Cordova Sciences, Inc. Financial ConglomeratesFinance Cordova Sciences, Inc. operates as a blank check company. It is a development stage company and serves as a vehicle to effect a merger, exchange of capital stock, and asset acquisition. The company was founded on August 12, 2005 and is headquartered in New York, NY. | Financial Conglomerates | President Corporate Secretary | |
Sitka Sciences, Inc.
 Sitka Sciences, Inc. Financial ConglomeratesFinance Sitka Sciences, Inc. operates as a development stage company. It intends to acquire or merge with an operating company. The company was founded on August 12, 2005 and is headquartered in Wilmington, DE. | Financial Conglomerates | President Chief Executive Officer | |
Riverbank Capital Securities, Inc.
 Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY. | Investment Banks/Brokers | Director/Board Member Director/Board Member Corporate Officer/Principal Chairman | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Mt. Cook Pharma, Inc.
 Mt. Cook Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mt. Cook Pharma, Inc. provides treatment for urological diseases. It offers services to overactive bladder, lower urinary symptoms, and interstitial cystitis diseases. The company was headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member | |
| FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Public Communications Contact | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Corporate Officer/Principal | |
| Orion Biomedical Fund LP | Corporate Officer/Principal Chief Investment Officer Corporate Officer/Principal Corporate Officer/Principal | ||
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| City University of New York | College/University | Undergraduate Degree Undergraduate Degree | |
| New York University | College/University | Masters Business Admin Masters Business Admin | |
| Yeshiva University | College/University | Doctorate Degree Undergraduate Degree | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| State University of New York at Binghamton | College/University | Undergraduate Degree | |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Investment Managers | Chief Executive Officer President General Counsel Chief Tech/Sci/R&D Officer Private Equity Investor | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder Founder | |
| Two River Group Management LLC | Director/Board Member President | ||
| Cancer Schmancer Foundation | Director/Board Member | ||
| Fran Dreschers Organization | Director/Board Member | ||
| Keren Or, Inc. | Director/Board Member | ||
| KITE PHARMA INC | Biotechnology | Founder Founder | |
| Fordham University School of Law | College/University | Graduate Degree Graduate Degree | |
Adgero Biopharmaceuticals Holdings, Inc.
 Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | Medical Specialties | Director/Board Member | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Founder | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Founder Founder | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Founder Founder | |
| Moonbow Ventures | Director/Board Member | ||
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder | |
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Director/Board Member |
Statistics
International
| United States | 50 |
| Israel | 2 |
Sectoral
| Health Technology | 25 |
| Finance | 10 |
| Consumer Services | 9 |
| Producer Manufacturing | 2 |
| Utilities | 2 |
Operational
| Director/Board Member | 135 |
| Corporate Officer/Principal | 63 |
| Founder | 46 |
| President | 32 |
| Independent Dir/Board Member | 29 |
Most connected contacts
| Insiders | |
|---|---|
| Joshua Kazam | 43 |
| Peter Morgan Kash | 32 |
| J. Lobell | 27 |
| Michael Weiser | 26 |
| David Tanen | 25 |
| Lindsay Rosenwald | 23 |
| Stephen Rocamboli | 20 |
| Ronald Simon | 19 |
| Timothy M. Hofer | 14 |
| Tim McInerney | 13 |
| Evan Renov | 12 |
| Michael Patrick George | 10 |
| Daniel DiPietro | 10 |
| Chad Messer | 8 |
| Larry Rowe | 7 |
- Stock Market
- Insiders
- Scott A. Katzmann
- Company connections
